Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled Phase II Study to Evaluate the Efficacy and Safety of SYHX1901 Tablets in the Treatment of Severe Alopecia Areata
Conditions
Interventions
SYHX1901
Placebo
Start Date
May 26, 2025
Primary Completion Date
May 31, 2027
Completion Date
November 17, 2027
Last Updated
June 3, 2025
NCT07029711
NCT07152119
NCT07029828
NCT07200128
Lead Sponsor
CSPC Ouyi Pharmaceutical Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions